Daily Stock List
Aeterna Zentaris, Inc. (AEZS)
Greenbackers, All about trends, OTCPicks, SmarTrend Newsletters, AllPennyStocks, StreetInsider, and The Street reported on Aeterna Zentaris, Inc. (AEZS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Founded in 1990, and headquartered in Quebec City, Quebec, Aeterna Zentaris, Inc. is an oncology and endocrinology drug development company. They are currently investigating treatments for a variety of unmet medical needs. Their pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. Aeterna Zentaris’ shares list on the NASDAQ Global Market and on the Toronto Stock Exchange under the symbol AEZ.
Pertaining to products on the market, the Company has their Cetrotide® product. It was the first luteinizing hormone-releasing hormone (LHRH) antagonist treatment approved for in vitro fertilization. It is administered to women to prevent premature ovulation in order to increase fertility success rates. It was developed in cooperation with Medicine Nobel Prize Winner Professor Andrew Schally, of Tulane University in New Orleans, Louisiana.
Aeterna Zentaris’ product pipeline includes Perifosine. This is an oral anticancer treatment that inhibits Akt activation in the PI3K pathway; it is in Phase III studies for the treatment of colorectal cancer and multiple myeloma, as well as in Phase II studies for the treatment of other cancers. Their pipeline also includes AEZS-108, a targeted cytotoxic peptide conjugate in Phase II studies for the treatment of endometrial, ovarian, prostate, and bladder cancer.
In addition, the Company is developing AEZS-130, an oral diagnostic test in Phase III trial for adult growth hormone deficiency, as well as in Phase I trial for the treatment of severe chronic diseases, including cancer induced cachexia. Their pipeline also includes AEZS-112. This is in Phase I clinical trial for the treatment of solid tumors.
Additionally, their product candidates in preclinical development include AEZS-115 for the treatment of multiple cancers, benign prostatic hyperplasia (BPH), and endometriosis; AEZS-129, 131, and 132 Erk and PI3K inhibitors for oncology; AEZS-120, a vaccine for prostate cancer and melanoma; AEZS-127 for the treatment of multiple cancers; AEZS-123 to treat obesity and related pathologies; and AEZS-137 for the treatment of solid tumors.
Recently, Aeterna Zentaris announced that a first patient was recruited for a Phase 2A trial with their ghrelin agonist, AEZS-130 in patients with cancer cachexia. The study is conducted under a Cooperative Research and Development Agreement (CRADA) between the Company and the Michael E. DeBakey Veterans Affairs Medical Center which is funding the study. Cachexia, characterized by diminished appetite and food intake in cancer patients, is defined as an involuntary weight loss of at least 5 percent of the pre-illness body weight over the previous 6 months.
Aeterna Zentaris, Inc. (AEZS), closed at $0.6698, up 21.80%, on 4,081,924 volume with 2,830 trades. The average volume for the last 60 days is 962,757 and the stock's 52-week low/high is $0.3767/$2.1664.
China Global Media, Inc. (CGLO)
OTCPicks and AllPennyStocks reported earlier on China Global Media, Inc. (CGLO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
China Global Media, Inc. primarily engages in the business of advertisement and brand name development in China. They do this especially in Hunan Province and other southern Chinese provinces. The Company was incorporated under the laws of the State of Nevada on November 3, 2008. China Global Media’s shares trade on the OTC Bulletin Board. The Company is based in Changsha, China. China Global Media is the leading advertising and brand name developing company in Hunan Province, China.
The Company’s business operations are carried out via their variable interest entities: Changsha North Latitude 30 Cultural Communications Co., Ltd., a limited liability company organized under the laws of the People's Republic of China (North Latitude); Changsha Beichen Cultural Communications Co., Ltd., a limited liability company organized under the laws of the People's Republic of China (Beichen), and Changsha Zhongte Trade Advertising Co., Ltd., a limited liability company organized under the laws of the People's Republic of China (Zhongte).
Each of the North Latitude, Beichen, and Zhongte has their own focus area. North Latitude and Beichen both specialize in automobile industrial advertisement and brand name development. North Latitude focuses on organizing the auto exhibitions and product promotional events and Beichen focuses on the advertisement coverage on regular media including TV channels, radio, as well as newspapers. Zhongte focuses on the advertisement of other industries, especially the food and textile industries.
China Global Media’s sales for 2011 were $35,930,827; they grew by 99 percent from their sales of $18,052,818 for 2010. The Company’s net income for 2011 was $7,843,628, which grew by 66 percent from their net income of $4,721,436 for 2010.
Their comprehensive income, which adds the currency adjustment to net income, was $8,223,375 for 2011. This grew by 68 percent from their comprehensive income of $4,883,377 for 2010. Their Earnings Per Share for 2011 was $ 0.20. This grew by 54 percent from the Earnings Per Share of $ 0.13 for 2010.
China Global Media, Inc. (CGLO), closed Thursday’s trading session at $0.08, down 11.11%, on 6,000 volume with 2 trades. The average volume for the last 60 days is 64,052 and the stock's 52-week low/high is $0.06/$2.05.
Response Genetics, Inc. (RGDX)
Wall Street Resources and TradingAuthority Daily reported earlier on Response Genetics, Inc. (RGDX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Trading on the NASDAQ Capital Market, Response Genetics, Inc. is a CLIA-certified clinical laboratory. The Company focuses on the development and sale of molecular diagnostic testing services for cancer. Their technologies enable the extraction and analysis of genetic information from genes derived from tumor samples stored as formalin-fixed and paraffin-embedded specimens. Founded in 1999, Response Genetics has their headquarters in Los Angeles, California.
In addition to diagnostic testing services, the Company generates revenue from the sales of their proprietary analytical pharmacogenomic testing services of clinical trial specimens to the pharmaceutical industry. Response Genetics’ principal customers include oncologists and pathologists. The Company also serves physician offices, and hospitals, as well as pharmaceutical companies and research organizations.
Response Genetics offers tests for non-small cell lung cancer, colorectal cancer, and gastric and gastroesophageal, and melanoma cancer patients tumor tissue specimens by way of their ResponseDX: Lung, ResponseDX: Colon, and ResponseDX: Gastric test suites, as well as under the ResponseDX: Melanoma name. In addition, they develop diagnostic tests for other types of cancer that identify genetic profiles of tumors, which recur after surgery. Furthermore, the Company engages in identifying genetic profiles of tumors that are responsive to a particular chemotherapy.
Today, Response Genetics announced that they entered into a purchase agreement with GlaxoSmithKline and one of their existing significant stockholders to raise $8.8 million from the private placement of 8,000,000 newly issued shares of their common stock at a purchase price of $1.10 per share. The signing of the purchase agreement and closing of the financing occurred today, Thursday, September 13, 2012.
Mr. Thomas Bologna, Chairman and Chief Executive Officer of Response Genetics, Inc., said, “We are pleased to welcome GlaxoSmithKline as a new investor, given our long standing relationship. The capital raised will help support our continued efforts in building a sustainable business of high value genetic tests for cancer patients as well as a premier pharmaceutical services business. Going forward we will continue to implement additional operational efficiencies, as evidenced by our improved financial performance relative to the fourth and subsequent quarters of last year, and will also increase our focus and efforts on growing top line revenue."
Response Genetics, Inc. (RGDX), closed Thursday’s trading at $1.23, up 36.67%, on 290,238 volume with 601 trades. The average volume for the last 60 days is 10,276 and the stock's 52-week low/high is $0.70/$2.40.
MMEX Mining Corp. (MMEX)
Stock Traders Chat, Outcast Traders, and SmallCapNetwork reported previously MMEX Mining Corp. (MMEX), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
MMEX Mining Corp. is a diversified mining company working on developing mining projects initially in Colombia and Peru.
The Company’s management team has extensive experience with natural resource project development and project financing in North and South America. An exploration stage enterprise, MMEX Mining engages in the acquisition and development of coal and other mining assets in South America. The Company’s shares list on the OTC Bulletin Board. MMEX Mining has their headquarters in Dallas, Texas.
Founded in 1986, the Company, as a developer, finances all the required pre-feasibility and feasibility studies to reach financial closing for a given project (technical, financial, environmental, and social). Correspondingly, MMEX Mining will structure the financing of the project, investing their own capital and bringing on board equity participants and financial institutions. The Company searches for commercially viable coal and mineral deposits by way of acquisitions. Mr. Jack W. Hanks founded Maple Resources Corp., MMEX Mining’s predecessor in the United States, in 1986. He has been President or Chairman of the Board of Maple Resources since their inception.
Concerning ongoing projects, MMEX Mining has their Hunza Mine. It consists of 50 million tons of metallurgical coal in the Boyaca province of Colombia. The Company’s project pipeline includes 10 million tons of metallurgical coal in Boyaca province; coal consolidation "Patio" in Boyacá province, and coking facilities in Boyaca province. Their project pipeline also includes a River Barge port on the Rio Magdalena, Colombia; an export terminal in Barranquilla, Colombia, as well as exploration phase mining projects in Peru.
In late August, MMEX Mining announced that on August 24, 2012, they filed a non-offering long form preliminary prospectus with the Alberta Securities Commission. In March 2012, MMEX successfully completed an initial equity capital raise in Lima, Peru via their engagement with Kallpa Securities S.A.B. The Company continues to review potential projects in metallurgical coal in Colombia and iron ore projects in Peru.
MMEX Mining Corp. (MMEX), closed Thursday’s session at $0.18, up 20.00%, on 30,000 volume with 1 trade. The average volume for the last 60 days is 7,858 and the stock's 52-week low/high is $0.0601/$0.50.
Pacific Wildcat Resources Corp. (PAW.V)
Today we are highlighting Pacific Wildcat Resources Corp. (PAW.V), here at the QualityStocks Daily Newsletter.
Pacific Wildcat Resources Corp. is a mineral exploration company with corporate headquarters in Vancouver, British Columbia. The Company is a mineral producer and explorer focusing on the development of several rare earth, tantalum, and niobium projects located in Africa. Their primary focus is on resource definition of the Mrima Hill Project in Kenya. Pacific Wildcat Resources lists on the TSX Venture Exchange and on the OTC Pink Current Information under the ticker symbol PWCRF.
The Company has a producing tantalum mine at Muiane in northern Mozambique. Here, it has the largest land position of more than 350 square kilometers on the Alto Ligonha pegmatite belt, the location of numerous historic tantalum mines. With the largest Tantalum license ground position in Mozambique, Pacific Wildcat has several mining leases located on parts of the Alto Ligonha pegmatite belt recognized as one of the premier mineralized pegmatite fields in the world. The leases cover several tantalum occurrences including the existing resource at the dormant Muiane Mine and various other historically mined areas. These areas of previous mining activity provide delineated exploration targets, both near surface and at depth.
Pacific Wildcat Resources’ flagship project is in Kenya, where a conditional contract is in place providing the Company the right to acquire an indirect 70 percent interest in the Mrima Hill niobium and rare earth project. This is an ex-Anglo American and Pechiney property; it was the subject of extensive historical work. The Company believes the Mrima hill rare earth and niobium property near Mombasa on the Kenyan coast has the potential to become a world class resource.
It is ideally located, being close to essential infrastructure with sealed roads and main power running adjacent to the deposit. The mineralized area is 75 kms by road from Mombasa, the largest deep water port in East Africa. In July 2011, Pacific Wildcat Resources’ completed an initial NI 43-101 compliant inferred niobium resource estimate of 105.3 million tonnes at 0.65 percent Nb2O5 for a total of 1.519 billion pounds contained Nb2O5 to a depth of 30 meters from the surface.
Pacific Wildcat Resources Corp. (PAW.V), closed Thursday’s trading session at $0.1050, up 16.67%, on 426,942 volume.
Searchlight Minerals Corp. (SRCH)
SmarTrend Newsletters and Stock Analyzer reported earlier on Searchlight Minerals Corp. (SRCH), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Searchlight Minerals Corp. is an exploration stage company whose shares trade on the OTC Bulletin Board. Based in Henderson, Nevada, the Company engages in the acquisition and exploration of mineral properties and slag reprocessing projects. Searchlight holds interests in two mineral projects: the Clarkdale Slag Project, located in Clarkdale, Arizona, and the Searchlight Gold Project, which involves exploration for precious metals on mining claims near Searchlight, Nevada.
The Clarkdale Slag Project is a reclamation project to recover precious and base metals from the reprocessing of slag produced from the smelting of copper ore mined at the United Verde Copper Mine in Jerome, Arizona. The Searchlight Gold Project is an early-stage gold exploration project on 3,200 acres located approximately 50 miles south of Las Vegas, Nevada. The Clarkdale Slag Project is the more advanced of the two ongoing projects that Searchlight Minerals is pursuing.
Since the Company’s involvement in the Clarkdale Slag Project, their objective has been to demonstrate the economic feasibility of the project by determining a commercially viable method to extract precious and base metals from the slag material. Searchlight Minerals believes that to demonstrate this, they must successfully operate the four major steps of their production process. These steps are crushing and grinding, leaching, continuous process operation, and the extraction of gold from solution. They believe that they have demonstrated success in the first three steps of the process. The Company is currently working to complete the fourth step prior to beginning the bankable feasibility process.
Since 2005, Searchlight Minerals has maintained an ongoing exploration program on their Searchlight Gold Project; they have contracted with Arrakis (an unaffiliated mining and environmental firm) to perform several metallurgical tests on surface and bulk samples taken from the project site under strict chain-of-custody protocols. In 2007, results from these tests validated the presence of gold on the project site, and identified reliable and consistent metallurgical protocols for the analysis and extraction of gold, such as microwave digestion and autoclave leaching.
On February 11, 2010, the Company received final approval of their Plan of Operations from the BLM. This allows them to conduct an 18-hole drill program on their project area. The Company has decided to postpone further exploration on their Searchlight Gold Project until they are better able to determine the feasibility of their Clarkdale Slag Project.
Searchlight Minerals Corp. (SRCH), closed Thursday’s trading session at $0.86, up 7.50%, on 73,495 volume with 33 trades. The average volume for the last 60 days is 49,081 and the stock's 52-week low/high is $0.57/$2.00.
Salamon Group, Inc. (SLMU)
OTC Gold Media, Alternative Energy, InvestmentDailyNews, RockingPennyStocks, FeedBlitz, BUYINS.NET, and SmallCapSociety reported earlier on Salamon Group, Inc. (SLMU), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Salamon Group, Inc., by way of their Sunlogics Power Fund Management, Inc. division, is a solar energy project company. On May 12, 2011, Salamon Group completed the acquisition of Sunlogics Power Fund Management. Salamon Group specializes in the construction management and acquisition of renewable energy power projects. Salamon Group lists on the OTCQB. The Company has their corporate headquarters in Kelowna, British Columbia.
Their Sunlogics Power also looks to acquire assets and other companies in the solar and renewable energy space that are a strategic fit. Sunlogics Power is also a project-acquiring partner of Sunlogics Plc and their Subsidiary as well as other third party project developers. Sunlogics Power Fund concentrates on the acquisition of solar powered electricity generating facilities that have long term power purchasing agreements in place with local power utilities and commercial users.
On March 2, 2012, Salamon Group completed the acquisition of the Systems Business and certain Silicon technology from Arise Technologies Corp. On March 16, 2012 the Company entered into an agreement to purchase 100 percent of the issued shares of ECO Energy Solutions Australia. On March 30, 2012, they executed an MOU and Binding Letter of Intent to acquire Solar Samoa Ltd. On April 25, 2012, Salamon Group entered into an asset purchase agreement with Avatar Solar, Inc. to acquire certain assets for consideration of $663,000 and $165,000 in a note payable.
Yesterday, Salamon Group’s and DayStar Technologies’ ECO Energy Solutions Australia Pty Ltd (EES) signed a contract with Jim's Solar to install residential and commercial solar power systems within South Eastern Australia. EES expects to complete up to an additional 1,500 installations annually because of this business partnership. Residential Solar systems for this area of Australia average $7,500 per system. Jim’s Solar is a wholly owned subsidiary of Jim's Building Maintenance Group.
ECO's Managing Director, Mr. Garry Yost, said, "This is a great opportunity adding value to both our organizations. This agreement further expands our renewable energy market in Australia. We are excited to be working with Jim's Solar, a division of the Jim's Group, and are one of the largest, longest operating, and most experienced home service organizations in the world. Australia claims to have installed more grid-connect residential systems than any country in the world. Due to EES's recognized leadership in this geographic area, Jim's has agreed that we are best suited to provide the solar services they need in South East Australia."
Salamon Group, Inc. (SLMU), closed Thursday’s trading session at $0.1930, up 16.97%, on 59,900 volume with 12 trades. The average volume for the last 60 days is 113,718 and the stock's 52-week low/high is $0.015/$1.10.
Aura Minerals, Inc. (ORA.TO)
We are highlighting Aura Minerals, Inc. (ORA.TO), here at the QualityStocks Daily Newsletter.
Headquartered in Vancouver, British Columbia, Aura Minerals, Inc. is a mid-tier gold and copper production company. They focus on the exploration, development, and operation of gold and base metal projects in the Americas. The Company's goal is to build a responsible and sustainable gold mining company in the Americas. Aura Minerals’ shares trade on the Toronto Stock Exchange.
The Company's producing assets include the San Andres gold mine in Honduras, the Sao Francisco and Sao Vicente gold mines in Brazil, and the copper-gold-silver Aranzazu Mine in Mexico. Their core exploration asset is the feasibility-stage copper-gold-iron ore Serrote Project in Brazil. Additionally, Aura Minerals has the Inaja iron ore project currently optioned to Vale.
The San Andres Mine is an open-pit heap leach gold mine located in the highlands of western Honduras and it covers 399 hectares. The San Andres Mine forms the solid base of production for Aura Minerals, with a current resource base of more than two million ounces of gold and excellent potential to increase resources.
The Sao Francisco mine is an open-pit, heap leach gold mine located in western Mato Grosso State, Brazil. The Sao Francisco Mine is 50 kilometers southeast of the Sao Vicente Mine, and at the center of a historic gold-producing district. The Sao Vicente Mine was acquired in May 2010 and is located in western Mato Grosso State, Brazil. The property consists of three contiguous mining concessions, covering approximately 29,000 hectares.
The Aranzazu mine is located within the Municipality of Concepción del Oro in the northeastern region of the State of Zacatecas, Mexico. It covers approximately 11,072 hectares, including the historical, past producing El Cobre area. Aura Minerals announced that commercial production at the copper-gold-silver Aranzazu mine was achieved on February 1, 2011.
Last week, Aura Minerals announced that they received the results of the Feasibility Study (FS) on their wholly owned Serrote da Laje property located near the city of Arapiraca in the state of Alagoas, Brazil. The FS describes the scope, design and viability of developing Serrote based on an open pit mining operation with a copper concentrator operating at 19,000 tonnes per day and producing approximately 66 million pounds of copper per year.
Selected highlights include an open pit mine and copper concentrator processing 7 million tonnes per year; production of 831 million pounds of copper and 171,000 ounces of gold over a 13 year mine life; and magnetite recovery and oxide ore treatment identified as future opportunities. Highlights also include satellite deposits remaining open and they may offer the potential to extend the mine life or lead to expansion, and projected production starting in mid-2015.
Aura Minerals, Inc. (ORA.TO), closed Thursday’s session at $0.4450, up 2.30%, on 19,301 volume. The stock's 52-week low/high is $0.29/$1.78.
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.28, up 5.77%, on 164,220 volume with 36 trades. The stock’s average daily volume over the past 60 days is 65,304, and its 52-week low/high is $0.21/$0.97.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corp Subsidiary Lifeline Skin Care Announces Entry Into Chinese Market
International Stem Cell Corp to Participate in Upcoming Investor Conferences
International Stem Cell Corp to Present at the Southern California Investor Conference on August 30, 2012
Teletouch Communications, Inc. (TLLE)
The QualityStocks Daily Newsletter would like to spotlight Teletouch Communications, Inc. (TLLE). Today, Teletouch Communications, Inc. closed trading at $0.54, up 12.50%, on 29,450 volume with 8 trades. The stock’s average daily volume over the past 60 days is 16,548, and its 52-week low/high is $0.253/$0.89.
Teletouch Communications, Inc. (TLLE) offers a comprehensive suite of wireless telecommunications solutions, including cellular, GPS-telemetry, and wireless messaging. Founded in 1964, the company provides its products and services to consumers, businesses, and government agencies, operating a chain of 11 retail and authorized agent stores, in conjunction with its direct sales force, call center operations, and various retail eCommerce websites.
Through its wholly owned subsidiary, Progressive Concepts, Teletouch operates a national distribution business, PCI Wholesale, primarily serving Tier-1 (AT&T, T-Mobile, Verizon, Sprint) cellular carrier agents, Tier-2, Tier-3, and rural carriers, as well as auto dealers and smaller consumer electronics retailers. The subsidiary's international sales coverage includes Canada, Mexico, Brazil, Singapore, and China.
The company is currently focusing on growing its core wholesale distribution business. The business plan being executed includes selling non-core corporate assets and reviewing potential acquisition opportunities. Operators and retailers of all sizes are seeking new sources of revenue at lower costs, creating a large opportunity to provide great products and value-added distribution capabilities at competitive prices.
Teletouch's management team has extensive experience in financing, acquiring, and operating retail, wireless and other related companies. Robert McMurrey, Chairman and CEO, guided Teletouch's original external expansion with the completion of over 15 acquisitions to date. Today, the company supports over 60,000 wireless customers, leveraging its long-standing relationships and global presence to drive future earnings growth. Disclaimer
Teletouch Communications, Inc. Blog
Teletouch Communications, Inc. News:
Teletouch Reports Fiscal Year 2012 Results
Teletouch 2012 Fiscal Year Ending May 31st Report Scheduled for August 29, 2012
Teletouch Sells Legacy Two-Way Radio Division to DFW Communications for $1.5 Million
TNI BioTech, Inc. (TNIB)
The QualityStocks Daily Newsletter would like to spotlight TNI BioTech, Inc. (TNIB). Today, TNI BioTech, Inc. closed trading at $1.05, up 11.11%, on 43,014 volume with 22 trades. The stock’s average daily volume over the past 60 days is 10,709, and its 52-week low/high is $0.253/$0.89.
TNI BioTech, Inc. (TNIB) is focused on utilizing patented immunotherapy to activate and mobilize the body's immune system to combat fatal diseases. The company's products and technologies improve the treatment and diagnosis of cancer, infections such as HIV/AIDS, and autoimmune diseases. Future initiatives include treatment for multiple sclerosis, herpes viral infections, and other conditions that result in altered-immune response.
The company's product portfolio currently includes IRT-101, an active immunotherapy that works by activating a patient's immune system against infectious diseases and tumor cells; IRT-102, an adaptive immunotherapy that works by isolating and enriching a patient's own immune cells; and IRT-103, an active immunotherapy that works by activating a patient's immune system against HIV/AIDS and tumor cells.
Leveraging the advantages of today's cutting-edge treatment options, the company aims to meet the growing demand for quality healthcare with safer, more effective radiation therapy; new-targeted drug therapies; and minimally invasive surgical alternatives around the world. TNI BioTech most recently signed a letter of intent to open clinics in Africa that will provide advanced treatment for cancer, HIV/AIDS, and autoimmune diseases.
The company plans to continue clinical trials in China during 2012 and 2013, and anticipates starting trials in the United States by early 2013.The company is also in negotiations to acquire a number of other immunotherapy products, patents, and therapies. Led by a management team with decades of experience and solid business plan, TNI BioTech is poised to improve healthcare with active and adaptive forms of improved immunotherapies. Disclaimer
TNI BioTech, Inc. Company Blog
TNI BioTech, Inc. News:
TNI BioTech, Inc. Signs Memorandum of Agreement to Open Pharmaceutical Plant for the Production of IRT-103 (LDN)
Dr. Ronald Herberman Joins TNI BioTech Inc. as Senior Vice President of Research and Development and Chief Medical Officer
TNI BioTech, Inc. Acquires Portfolio of Exclusive Licenses to the Portfolio of Patents of Dr. Bernard Bihari
Longhai Steel, Inc. (LGHS)
The QualityStocks Daily Newsletter would like to spotlight Longhai Steel, Inc. (LGHS). Today, Longhai Steel, Inc. closed trading at $1.05, even with yesterday's close, on 5,700 volume with 6 trades. The stock’s average daily volume over the past 60 days is 13,630, and its 52-week low/high is $0.15/$2.26.
Longhai Steel, Inc. (LGHS) is a leading producer of high-quality steel wire in eastern China, with annual capacity of 1.5 million metric tons. Longhai's wire is manufactured into screws, nails, and wire mesh used for fencing and to reinforce concrete. Longhai recently expanded its production facility to include specialized applications such as steel wire rope, steel strand, steel belted radial tires, and steel welding rod. Longhai Steel is headquartered in Xingtai, Hebei province, the People's Republic of China.
The company's competitive advantages are its advanced production equipment and process technology, high product quality, expedited production, and close proximity to distributors and end users. Longhai Steel recently opened a second production line, which increases its overall capacity by 67% and expands its product portfolio into higher quality steel wire for specialized applications such as steel wire rope, steel strand, steel belted radial tires, and steel welding rod.
Longhai Steel's growth strategy includes capitalizing on government actions aimed at encouraging industry consolidation via the acquisition of neighboring producers at attractive valuations. The company also plans to grow organically through capacity expansion, broadening its product portfolio, improving operating efficiencies, and continued expansion of technical expertise.
China is the world's largest producer and consumer of steel and steel wires. Demand for steel products is primarily driven by spending in the construction, automotive, and infrastructure industries in China. Continued economic development in Hebei, one of the largest steel manufacturing regions in China, and neighboring provinces, and further buildout of tier 3-6 cities in China, provide tremendous medium and long term opportunities for Longhai Steel. Disclaimer
Longhai Steel, Inc. Company Blog
Longhai Steel, Inc. News:
Longhai Steel Completes Testing of New Steel Wire Facility
Longhai Steel Provides Q2 2012 Earnings Call Transcript; Gross Profit Up 34%, EPS up 32%
Longhai Steel Announces Strong Second Quarter 2012 Operating Results
A recent article in Review of Ophthalmology, by Senior Editor Christopher Kent, centers on the stem cell revolution and how it’s in the process of fundamentally changing the treatment of eye disease. Parts of the article point specifically to International Stem Cell Corporation, and how the company is using human parthenogenetic stem cells, derived from unfertilized human eggs, to generate corneal tissue. In particular, the article quotes Jeffrey Janus, Sr. Vice President at ISCO, and Rusian Semechkin, PhD and Vice President of Research & Development for the company.
Dr. Semechkin points out that ISCO is approaching the development of corneal tissue from two different directions. In addition to deriving corneal tissue from stem cells, the company is directly deriving corneal endothelial-like cells from stem cells using a new differentiation method they’ve just developed. Dr. Semechkin heads the second approach and uses protocols developed by ISCO that can specify how stem cells behave. Dr. Semechkin indicates that they hope to ultimately generate a complete cornea, and notes that the company’s parthenogenetic stem cells have several advantages over embryonic stem cells, one of which is immune-matching. Parthenogenetic stem cells created from individuals who carry a common immune type, or haplotype, can be made to match millions of people. Another advantage is that such cells do not involve the destruction of a human embryo, avoiding the associated ethical issue. Also, parthenogenetic stem cells can be genetically screened to ensure that they don’t carry the genetic disorder that is being treated. For these reasons, Dr. Semechkin believes, importantly, that parthenogenetic stem cells will someday become the principal type of stem cells used.
Besides corneal tissue, Mr. Janus states that the company is also working on producing retinal tissue from parthenogenetic stem cells. The cornea is in the front of the eye, an area that is immune-privileged, meaning that it can tolerate the introduction of antigens without eliciting a harmful immune response. But the retina is in the back of the eye, an area of more vascularization, where there is a greater chance of immune rejection. It’s possible that parthenogenetic stem cells, which can be immune-matched, may have an advantage in this area over embryonic stem cells that are not immune-matched.
For additional information on ISCO, visit the company’s website atwww.InternationalStemCell.com
AbTech Holdings, long recognized for their innovations in the field of full-service environmental technology/engineering, announced being chosen as one of the Top 50 for the fourth consecutive year in this year’s Artemis Top 50 Water Tech Listing™.
The Artemis Top 50 is an influential bracket developed by specialized consulting firm Artemis Water Strategy™ in order to showcase the top companies every year in water management. Artemis sits at the nexus between corporate strategy, cutting-edge technologies, investment, and government policy, helping water tech companies maximize sustainable competitiveness in an industry that is struggling to come to terms with water scarcity.
The Top 50 throws a spotlight on companies like AbTech which have developed innovations that will produce real ground-breaking impact within the sector. AbTech was picked from a crowded pool of candidates due to their impressive track record of developing efficient, cost-effective water contamination solutions for problems like hydrocarbons which have polluted a large body of water. The esteemed group of jurists which handled selection from the pool of candidates represents some of the most influential people in the field today, from top operators like Archer Daniels Midland, Ecolab, IBM, Intel, and Syngenta.
CEO of ABHD, Glenn Rink, citing what an honor it was to receive this important industry recognition for the fourth year in a row now, underscored the company’s rich portfolio of 17 U.S. patents spanning a whole variety of technologies, with the company’s Smart Sponge for outdoor use, the first product of its kind to receive EPA-registration, being the prime example. The Canadian Intellectual Property Office even issued a Notice of Allowance on the Smart Sponge recently for an additional patent, further strengthening the company’s IP portfolio in what is increasingly a globally-focused space.
Rink emphasized the company’s continued efforts to branch out into new water contaminant solutions, like removing heavy metals from vital waterways, clearly tipping his hat to shareholders that AbTech would not merely be sitting on its laurels in the “extremely large” primary markets already addressed. The Cleantech Group Water Innovation Summit being held today in Berkley will honor the Top 50, in an event formed to assist in igniting shared passions between corporate and technological players, helping to speed time to market for new technologies.
Chair of the Top 50, Laura Shenkar, a leading expert in advanced water technology, with over two decades launching paradigm-shattering new technologies into the stratosphere, called the Artemis Top 50 an innovation benchmark for the water industry, pointing out how the Top 50 represents the cream of the crop among startups emerging in the high tech water sector.
For more information on AbTech Holdings or its subsidiary, AbTech Industries, please visit: www.abtechindustries.com
Or, to learn more about the company’s civil and environmental engineering subsidiary, AEWS Engineering, visit: www.aewsengineering.com
ModusLink Global Solutions has announced a collaboration with PagBrasil to provide e-commerce transaction support in Brazil. Payment options and tax issues are complex in that country, but with this new agreement ModusLink will be able to provide its e-commerce customers with easy access to one of the fastest growing markets in the world.
As indicated in a recent report from Forrester Research, e-commerce in Brazil will surpass $12 billion this year. Companies desiring to conduct consumer-facing business in Brazil must be able to navigate the country’s abundant and unique payment options for goods and services, which include local credit cards, installment plans, cash deposits, and payment programs that are managed by national banks. ModusLink will be able to seamlessly integrate PagBrasil’s payment support services into clients’ existing e-commerce sites and offer product fulfillment and shipping services from any of ModusLink’s worldwide facilities.
A good fit for both companies, this strategic agreement between ModusLink and PagBrasil will allow ModusLink’s clients to confidently grow their online businesses with the backing of the company’s 15 years of experience in processing complex payment transactions. PagBrasil stands to benefit from the global scope of ModusLink’s operations and the opportunity to support its vast and growing client roster.
ModusLink’s clients depend on the company’s proven track record of providing secure, reliable online shopping sites that conform to each client’s unique brand. It was PagBrasil’s proven, robust IT infrastructure that attracted ModusLink, and that infrastructure will allow the company to continue surpassing customer expectations for a superb online marketplace. This added ability to speedily serve the major commercial region of Brazil is a prime opportunity for ModusLink’s clients.
In addition to expanding its services to Brazil, ModusLink currently manages all aspects of multilingual and multicurrency e-commerce solutions for clients in North America, Europe, and the Asia/Pacific region.
ModusLink Global Solutions provides comprehensive supply chain and logistics services to improve revenue, cost, sustainability, and customer experience objectives for its clients. The company serves the world’s leading consumer electronics, communications, computing, medical device, software, luxury goods, and retail companies. ModusLink’s operating infrastructure supports more than $80 billion of its clients’ revenue each year and manages around 470 million product shipments through more than 30 sites in 15 countries throughout North America, Europe, and the Asia/Pacific region.
Leading digital financial media company, TheStreet, announced that it has acquired The Deal LLC from Wasserstein & Co. Founded in 1999, The Deal LLC is a digital subscription platform that delivers coverage of the deal economy through The Deal Pipeline. The Deal Pipeline provides full access to 100-plus pieces of proprietary commentary, analysis, and data every day and can be customized based on each client’s job function, deal focus, and workflow and delivered straight to a mobile device or existing corporate platform.
The Deal’s and TheStreet’s content-creation and market resources will be leveraged to create new revenue opportunities, specifically, The Street’s buy-side newsroom content will be incorporated into The Deal Pipeline to accelerate sales to hedge funds. Similarly, TheStreet’s Chat-on-the-Street product will be added to the product set sold by The Deal’s enterprise sales force, and The Deal Pipeline will be marketed across the entire network of The Street, creating a substantial increase in qualified leads. These strategic and operational opportunities, when added to significant corporate synergies, will be accretive to TheStreet’s consolidated adjusted EBITDA.
TheStreet’s CEO, Elisabeth DeMarse, remarked, “This is a terrific combination that grows the most profitable portion of our business, subscription revenues. The Deal is a prominent and well-respected brand that the market will intuitively associate with TheStreet, creating new revenue opportunities for both businesses at minimal incremental cost.”
“This combination will build upon our digital strategy and is a great opportunity to move the business forward to better serve customers,” Kevin Worth, CEO of The Deal, added.
Acquiring The Deal will advance TheStreet’s strategic objectives by increasing both subscribers and content. The Deal’s marquee customer base of 40,000 professionals includes senior-level bankers, law firm partners, private equity partners, and hedge fund notable. This fact alone provides substantial predictable recurring revenue with high renewals and attractive margins.
To learn more about TheStreet, visit www.thestreet.com
Today's Top 3
The QualityStocks Public Company Sponsor News